United States investigates E. coli and infant botulism outbreaks
Tap title to read story
U.S. federal health authorities are investigating a new Escherichia coli O157:H7 outbreak and a concurrent surge in infant botulism cases, according to information released this week. The Food and Drug Administration and the Centers for Disease Control and Prevention have begun coordinated traceback efforts to identify the contaminated food source behind at least 14 E. coli infections reported across multiple states. Officials have not yet disclosed patient demographics, precise locations, or the suspected food vehicle. In parallel, the FDA has launched intensive inspections at manufacturing and packaging facilities tied to infant botulism cases linked epidemiologically to Nara Organics Whole Milk Organic Powdered Infant Formula.
More context
Timeline
- Recent weeks E. coli O157:H7 outbreak detected nationwide
- Recent weeks At least 14 patients reported sick
- Recent weeks FDA, CDC begin coordinated traceback
- Recent weeks Geographic and product details withheld
- Recent weeks Infant botulism outbreak epidemiologically linked
- Recent weeks Three lab-confirmed infant botulism cases
- Recent weeks FDA inspects related manufacturing facilities
- Recent weeks Nara Organics initiates voluntary response
Why it matters
Your family's health could be at risk. The E. coli outbreak and infant botulism cases are serious. The source is still unknown. Until it's found, be extra careful with food safety. Check the FDA's recall list regularly.
JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.
